share_log

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY

SEC ·  Jun 18 04:11
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.